Skip to main content
. 2017 Oct 31;44(6):617–630. doi: 10.1007/s10928-017-9553-x

Fig. 2.

Fig. 2

Tumor growth inhibiton profiles (mean data) per treatment and dose group. Gefitinib is shown in red and erlotinib in blue. Dosing schedule is indicated as small cubes above the curves